OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $420,321 Invested

2019

Centre for Eye Research Australia

Peter van Wijngaarden, MBBS, PhD, FRANZCO

A non-invasive retinal biomarker as a screening test for Alzheimer’s disease

  • Funding Amount: $420,321
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Abeta
  • Status: Closed